Default: American Journal of Clinical Oncology: Cancer Clinical Trials

ISSN: 1537-453X

Journal Home

Journal Guideline

American Journal of Clinical Oncology: Cancer Clinical Trials Q3 Unclaimed

Lippincott Williams and Wilkins United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

American Journal of Clinical Oncology: Cancer Clinical Trials is a journal indexed in SJR in Oncology and Cancer Research with an H index of 93. It has an SJR impact factor of 0,696 and it has a best quartile of Q3. It has an SJR impact factor of 0,696.

American Journal of Clinical Oncology: Cancer Clinical Trials focuses its scope in these topics and keywords: cancer, patients, breast, cell, chemotherapy, neoadjuvant, therapy, advanced, physical, radiotherapy, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

American Journal of Clinical Oncology: Cancer Clinical Trials

0,696

SJR Impact factor

93

H Index

103

Total Docs (Last Year)

271

Total Docs (3 years)

3456

Total Refs

438

Total Cites (3 years)

251

Citable Docs (3 years)

1.67

Cites/Doc (2 years)

33.55

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


cancer, patients, breast, cell, chemotherapy, neoadjuvant, therapy, advanced, physical, radiotherapy, stereotactic, tumor, adenocarcinoma, adjuvant, adrenal, advancedstage, alternating, apnea, approaches, association, body, brain, cancerlapatinibgemcitabine, cancerphase, candidatespretreatment, capecitabine, carcinomaradiotherapy, carcinomatargeting, care, chemoradiation, chemoresistant, chinese, combined, complete, conjunction, conservation, contralateral, cord, cyclophosphamide, dactinomycin,

FAQS